Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00314158 · ClinicalTrials.gov registry record · Phase 3
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
A Phase 3 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 523
- Enrollment target
NCT00314158: Completed Phase 3 study, sponsored by Alcon Research.
NCT00314158 is a Phase 3 study that has completed, run by Alcon Research. The registered enrollment target is 523 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (32% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00314158, a Phase 3 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 523 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.
Interventions
- DRUG Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension
- DRUG Brinzolamide 10 mg/ml (AZOPT) eye drops, suspension
- DRUG Timolol 5 mg/ml eye drops, solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 523 participants |
| Start Date | 2005-11 |
| Est. Completion | 2007-01 |
| Phase | Phase 3 |
What the finished NCT00314158 record still lists
NCT00314158 is an interventional study that assigns participants to a tested intervention. The registered 523 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (32% lower).
The record links to 0 conditions, and to 3 interventions - of which Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension is the first listed.
NCT00314158 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00314158 about?
NCT00314158 is a clinical study titled "A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension". The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.
What is the current status of trial NCT00314158?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 523 participants. The study started on 2005-11. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00314158?
The interventions under investigation include: Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension (DRUG), Brinzolamide 10 mg/ml (AZOPT) eye drops, suspension (DRUG), Timolol 5 mg/ml eye drops, solution (DRUG).
Who is sponsoring clinical trial NCT00314158?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00314158's enrollment target sits among peer trials
523 716th of 2000 higher than 1,285 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03526835 · 523 participants · Phase 1
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- NCT04580134 · 524 participants · Phase 4
CLOZAPINE Response in Biotype-1
- NCT07158814 · 524 participants · Phase 4
Safety of RSV Preventive Monoclonal Antibody
- NCT06835686 · 522 participants · NA
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia